(S1 (S (S (NP (NP (NP (JJ Comparative) (NN NMR) (NN study)) (PP (IN of) (NP (DT a) (VBN differentiated) (NN rat) (NN hepatoma)))) (CC and) (NP (PRP$ its) (JJ dedifferentiated) (NN subclone))) (VP (VBN cultured) (PP (PP (IN as) (NP (NNS spheroids))) (CC and) (PP (IN as) (NP (JJ implanted) (NNS tumors)))))) (. .)))
(S1 (S (S (NP (NP (NP (NN H4IIEC3) (-LRB- -LRB-) (NN H4) (-RRB- -RRB-)) (, ,) (NP (DT a) (VBN differentiated) (NN rat) (NN hepatoma) (NN line)) (CC and) (NP (NN H5))) (, ,) (NP (PRP$ its) (JJ dedifferentiated) (NN subclone)) (, ,)) (VP (VBD were) (VP (VBN investigated) (PP (PP (IN as) (NP (VBG proliferating) (NNS spheroids))) (CC and) (PP (IN as) (NP (NP (JJ implanted) (JJ subcutaneous) (NNS tumors)) (PP (IN in) (NP (JJ juvenile) (NNS rats))))))))) (. .)))
(S1 (S (S (NP (NN H4) (NNS cells)) (VP (VBD formed) (NP (ADJP (ADJP (JJ tight)) (, ,) (ADJP (JJ round))) (NNS spheroids)) (SBAR (IN whereas) (S (NP (NN H5) (NNS cells)) (VP (VBD formed) (NP (ADJP (ADJP (JJ loose)) (, ,) (ADJP (JJ grape-like))) (NNS structures))))))) (. .)))
(S1 (S (S (NP (NN 31P) (NN MR) (NNS spectra)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN phosphocreatine)) (VP (VBD was) (ADJP (JJ present) (PP (PP (IN in) (NP (NN H5) (NNS spheroids))) (CC but) (PP (RB not) (IN in) (NP (NP (NN H4) (NNS spheroids)) (CC or) (NP (NNS tumors))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ -LSB-13C-RSB-Lactate) (NN production)) (PP (IN from) (NP (NN -LSB-13C-RSB-glucose))) (, ,) (PP (IN with) (NP (NP (DT no) (JJ detectable) (NN uptake)) (PP (IN of) (NP (NN -LSB-13C-RSB-alanine))))) (, ,)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (NN energy) (NN production)) (PP (IN in) (NP (NN H5) (NNS spheroids)))) (VP (VBD was) (ADVP (RB primarily)) (PP (IN via) (NP (NN glycolysis)))))))) (. .)))
(S1 (S (S (S (NP (DT No) (JJ -LSB-13C-RSB-glucose) (NN utilization)) (VP (VBD was) (VP (VBN detected) (PP (IN in) (NP (NN H4) (NNS spheroids)))))) (, ,) (CC but) (S (NP (NP (NN uptake)) (PP (IN of) (NP (NP (NP (NN alanine)) (CC and) (NP (NP (NN accumulation)) (PP (IN of) (NP (JJ labeled) (NN lactate))))) (, ,) (NP (NN glutamate)) (CC and) (NP (NN glutamine))))) (VP (VBD indicated) (NP (NN oxidation)) (PP (IN via) (NP (DT the) (JJ tricarboxylic) (NN acid) (-LRB- -LRB-) (NN TCA) (-RRB- -RRB-) (NN cycle)))))) (. .)))
(S1 (S (S (NP (NP (NNS Tumors)) (PP (IN of) (NP (NN H4) (NNS cells)))) (VP (VBD were) (ADVP (RB well)) (VP (VBN perfused) (, ,) (PP (IN unlike) (NP (NP (NNS tumors)) (PP (IN of) (NP (NN H5) (NNS cells))) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADJP (RB highly) (JJ necrotic)))))))))) (. .)))
(S1 (S (S (PP (VBG Following) (NP (NP (NN i.v.) (NN infusion)) (PP (IN with) (NP (NN -LSB-13C-RSB-alanine))))) (, ,) (NP (NP (NP (NN -LSB-13C-RSB-lactate)) (CC and) (NP (NN glutamate))) (, ,) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NN oxidation)) (PP (IN via) (NP (DT the) (NN TCA) (NN cycle)))))) (, ,)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NN H4) (NNS tumors)))))) (. .)))
(S1 (S (S (NP (NP (RB Thus) (DT the) (NNS results)) (VP (VBN obtained) (PP (IN by) (NP (NP (NP (NN 31P)) (CC and) (NP (NN 13C))) (NNS MRS))))) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN differentiation) (NN state)) (PP (IN of) (NP (NP (NP (NP (NN H4)) (CC and) (NP (NN H5))) (NNS spheroids)) (CC and) (NP (NNS tumors)))))))) (. .)))
